NYLIM
IRMD icon

New York Life Investment Management’s iRadimed IRMD Stock Holding History

New York Life Investment Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,776
Closed -$417K – 1431
2023
Q4 		$417K Sell
8,776
-258
-3% -$10.8K ﹤0.01% 964
2023
Q3 		$401K Sell
9,034
-1,440
-14% -$66.9K ﹤0.01% 869
2023
Q2 		$500K Sell
10,474
-1,504
-13% -$67.8K 0.01% 721
2023
Q1 		$471K Buy
+11,978
New +$435K 0.01% 1069

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

New York Life Investment Management's IRMD Position: Q1 2024 in Review

New York Life Investment Management sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 8,776 shares — an estimated $417K sold.

New York Life Investment Management first reported a position in IRMD in Q1 2023 and held it in 4 quarters. The position peaked at $500K in Q2 2023. 127 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.

  • New York Life Investment Management reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
  • New York Life Investment Management sold 8,776 iRadimed shares in Q1 2024, an estimated $417K.
  • New York Life Investment Management first reported a position in iRadimed in Q1 2023 and held it in 4 quarters.
  • New York Life Investment Management's iRadimed position peaked at $500K in Q2 2023.
  • 127 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.

Based on New York Life Investment Management's 13F filing for Q1 2024, filed 6 May 2024.